Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.

Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of Carbidopa, Levodopa and Entacapone tablets used in treatment of Parkinson's ...

Shares of Alembic Pharmaceuticals came under pressure on Friday, falling 4.22 per cent to an intraday low of ₹776.20 per share on the NSE, after the company reported a 4 per cent decline in ...

Alembic Pharmaceuticals reported a steady operating performance in Q3, with revenue rising 10.8% year-on-year to ₹1,876.3 crore, supported by consistent execution across domestic and international ...

Alembic Pharmaceuticals Ltd on Wednesday said it has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Difluprednate ...

Difluprednate ophthalmic emulsion is indicated for the treatment of inflammation and pain associated with ocular surgery and also indicated for the treatment of endogenous anterior uveitis. New Delhi: ...

No TypeScript, No JavaScript, No Jinja2 100% Python. Type-safe, declarative HTML building and modern web app features with minimal stack. Ideal for Python developers who want to build modern web apps ...

Sometimes, you need to set up an OCR microservice, which accepts images and returns text. In this article, I will try to explain basic ideas on how to create your own OCR service for free, using ...

International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...